Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Adaptimmune Therapeutics PLC ADR buy BiotechBee

Start price
€0.98
04.02.24 / 60%
Target price
€1.50
31.10.25
Performance (%)
2.04%
Price
€1.00
26.04.24
Summary
This prediction is currently active. The BUY prediction by BiotechBee shows slight gains of 2.04%. This prediction currently runs until 31.10.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m
Adaptimmune Therapeutics PLC ADR 9.290% 9.290%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

According to BiotechBee what are the pros and cons of Adaptimmune Therapeutics PLC ADR for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Adaptimmune Therapeutics PLC ADR diskutieren
Prediction Buy
Perf. (%) 2.04%
Target price 1.500
Change
Ends at 31.10.25

Buy mit Kursziel 1,5